USA Rare Earth to acquire Serra Verde in $2.8 billion deal
USA Rare Earth (NASDAQ:USAR) has announced a definitive agreement to acquire Serra Verde Group for a total consideration of approximately $2.8 billion.
United StatesBreaking News
Greenwich LifeSciences reports significant immune response in Phase III breast cancer trial
Greenwich LifeSciences (NASDAQ:GLSI) today presented a significant update on its clinical progress at the 2026 American Association for Cancer Research (AACR) Annual Meeting.
Ennis reports full-year earnings growth as fiscal 2026 margins expand
Ennis (NYSE:EBF), a manufacturer of printed business products and apparel, today announced financial results for the fourth quarter and the full fiscal year ended February 28, 2026.
Industrials
Cleveland-Cliffs revenues surge on record shipments
Cleveland-Cliffs (NYSE:CLF), the largest flat-rolled steel producer in North America, reported a significant sequential increase in operational volume and revenue for the first quarter ended March 31, 2026.
Technology
Indian antitrust watchdog fast-tracks Apple penalty decision following data refusal
Apple (NASDAQ:AAPL) is facing an accelerated timeline for potential antitrust penalties in India after the nation’s competition watchdog fast-tracked a decision to a final hearing next month.
Oculis completes patient follow-up in pivotal Phase 3 diabetic macular edema trials
Oculis Holding (NASDAQ:OCS), a global biopharmaceutical company focused on ophthalmic breakthroughs, announced today the completion of the final patient visits in its DIAMOND Phase 3 clinical program.
Monopar ALXN1840 outperforms standard treatment in Phase 3 Wilson disease trial
Monopar Therapeutics (NASDAQ:MNPR) reported positive topline results from its Phase 3 FoCus study, marking a significant milestone in the development of ALXN1840 for patients with Wilson disease.
Sutro Biopharma showcases next-gen ADC pipeline strength at AACR 2026
Sutro Biopharma (NASDAQ:STRO) unveiled a series of preclinical successes at the 2026 American Association for Cancer Research (AACR) Annual Meeting, reinforcing its leadership in the design of next-generation antibody-drug conjugates (ADCs).
Nanobiotix Nanoprimer enhances LNP-DNA delivery, reduces liver toxicity in preclinical trials
Nanobiotix (NASDAQ:NBTX), a late-clinical stage biotechnology company, announced the presentation of new preclinical data today at the 2026 Annual Meeting of the American Association for Cancer Research (AACR).
_1383253_640x360_2496987203809-640x360.webp&w=3840&q=75)
Iran Can Sustain the War for Months: Johns Hopkins' Slim
Randa Slim, Johns Hopkins University SAIS Senior Fellow, speaks to Bloomberg TV about the next steps for Iran and the US after back-and-forth over potential peace talks in Islamabad this week.
Bank Debate Interview: Umar Farooq and Shahmir Khaliq
Global Co-Head of JP Morgan Payments, Umar Farooq and Head of Services at Citi, Shahmir Khaliq, spoke with Bloomberg's Emily Mason in a bank debate interview.
Pointed News Quiz | Investigations, Business Leaders, Cons
Bloomberg Tech Co-Host Ed Ludlow joins David Gura, Christina Ruffini, and Lisa Mateo on "Bloomberg This Weekend" to play Pointed! Wager your points, leverage your bets and answer wisely. A new quiz is available to play each week on Bloomberg.com